These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

599 related items for PubMed ID: 27973391

  • 21. Antibody-Mediated Rejection in Kidney Transplantation Without Evidence of Anti-HLA Antibodies?
    Irure J, López-Hoyos M, Rodrigo E, Gómez-Román J, Ruiz JC, Arias M, San Segundo D.
    Transplant Proc; 2016 Nov; 48(9):2888-2890. PubMed ID: 27932099
    [Abstract] [Full Text] [Related]

  • 22. The influence of non-HLA antibodies directed against angiotensin II type 1 receptor (AT1R) on early renal transplant outcomes.
    Banasik M, Boratyńska M, Kościelska-Kasprzak K, Kamińska D, Bartoszek D, Zabińska M, Myszka M, Zmonarski S, Protasiewicz M, Nowakowska B, Hałoń A, Chudoba P, Klinger M.
    Transpl Int; 2014 Oct; 27(10):1029-38. PubMed ID: 24909812
    [Abstract] [Full Text] [Related]

  • 23. Pre-transplant AT1R antibodies correlate with early allograft rejection.
    Gareau AJ, Wiebe C, Pochinco D, Gibson IW, Ho J, Rush DN, Nickerson PW.
    Transpl Immunol; 2018 Feb; 46():29-35. PubMed ID: 29217423
    [Abstract] [Full Text] [Related]

  • 24. The Presence of Pretransplant HLA Antibodies Does Not Impact the Development of Chronic Lung Allograft Dysfunction or CLAD-Related Death.
    Zazueta OE, Preston SE, Moniodis A, Fried S, Kim M, Townsend K, Wood I, Boukedes S, Guleria I, Camp P, El-Chemaly S, Rosas IO, Chandraker A, Milford E, Goldberg HJ.
    Transplantation; 2017 Sep; 101(9):2207-2212. PubMed ID: 27893614
    [Abstract] [Full Text] [Related]

  • 25. Non-HLA agonistic anti-angiotensin II type 1 receptor antibodies induce a distinctive phenotype of antibody-mediated rejection in kidney transplant recipients.
    Lefaucheur C, Viglietti D, Bouatou Y, Philippe A, Pievani D, Aubert O, Duong Van Huyen JP, Taupin JL, Glotz D, Legendre C, Loupy A, Halloran PF, Dragun D.
    Kidney Int; 2019 Jul; 96(1):189-201. PubMed ID: 31005275
    [Abstract] [Full Text] [Related]

  • 26. Investigation of Serum Angiotensin II Type 1 Receptor Antibodies at the Time of Renal Allograft Rejection.
    Lee H, Kim JI, Moon IS, Chung BH, Yang CW, Kim Y, Han K, Oh EJ.
    Ann Lab Med; 2015 May; 35(3):314-20. PubMed ID: 25932439
    [Abstract] [Full Text] [Related]

  • 27. Non-HLA Antibodies to G Protein-coupled Receptors in Pediatric Kidney Transplant Recipients: Short- and Long-term Clinical Outcomes.
    Pearl MH, Chen L, Zuckerman JE, Weng PL, Chambers ET, Zhang Q, Reed EF.
    Transplantation; 2024 Jan 01; 108(1):276-283. PubMed ID: 37527494
    [Abstract] [Full Text] [Related]

  • 28. Association of angiotensin II type 1 receptor antibodies with graft histology, function and survival in paediatric renal transplant recipients.
    Fichtner A, Süsal C, Schröder C, Höcker B, Rieger S, Waldherr R, Westhoff JH, Sander A, Dragun D, Tönshoff B.
    Nephrol Dial Transplant; 2018 Jun 01; 33(6):1065-1072. PubMed ID: 29444269
    [Abstract] [Full Text] [Related]

  • 29. Pretransplant donor-specific HLA antibodies detected by single antigen bead flow cytometry: risk factors and outcomes after kidney transplantation.
    Kanter Berga J, Sancho Calabuig A, Gavela Martinez E, Puig Alcaraz N, Beltran Catalan S, Avila Bernabeu A, Crespo Albiach J, Montoro JA, Pallardo Mateu LM.
    Transplant Proc; 2012 Nov 01; 44(9):2529-31. PubMed ID: 23146444
    [Abstract] [Full Text] [Related]

  • 30. Characteristics of Circulating Donor Human Leukocyte Antigen-specific Immunoglobulin G Antibodies Predictive of Acute Antibody-mediated Rejection and Kidney Allograft Failure.
    Kannabhiran D, Lee J, Schwartz JE, Friedlander R, Aull M, Muthukumar T, Campbell S, Epstein D, Seshan SV, Kapur S, Sharma VK, Suthanthiran M, Dadhania D.
    Transplantation; 2015 Jun 01; 99(6):1156-64. PubMed ID: 25629531
    [Abstract] [Full Text] [Related]

  • 31. Prevalence and Clinical Impact of Donor-Specific Alloantibody Among Intestinal Transplant Recipients.
    Cheng EY, Everly MJ, Kaneku H, Banuelos N, Wozniak LJ, Venick RS, Marcus EA, McDiarmid SV, Busuttil RW, Terasaki PI, Farmer DG.
    Transplantation; 2017 Apr 01; 101(4):873-882. PubMed ID: 27490417
    [Abstract] [Full Text] [Related]

  • 32. Donor-specific HLA antibodies: risk factors and outcomes after kidney transplantation.
    Kanter Berga J, Pallardo Mateu LM, Beltran Catalan S, Puig Alcaraz N, Sancho Calabuig A, Gavela Martinez E, Avila Bernabeu A, Crespo Albiach J.
    Transplant Proc; 2011 Apr 01; 43(6):2154-6. PubMed ID: 21839219
    [Abstract] [Full Text] [Related]

  • 33. Novel insights into pretransplant allosensitization in heart transplant recipients in the contemporary era of immunosuppression and rejection surveillance.
    Svobodova E, Gazdic T, Kubanek M, Vymetalova J, Voska L, Kment M, Lanska V, Kolesar L, Urban M, Netuka I, Pirk J, Melenovsky V, Kautzner J, Slavcev A, Malek I.
    Transpl Int; 2016 Jan 01; 29(1):63-72. PubMed ID: 26340387
    [Abstract] [Full Text] [Related]

  • 34. Impact of alloantibody strength in crossmatch negative DSA positive kidney transplantation.
    Wu P, Jin J, Everly MJ, Lin C, Terasaki PI, Chen J.
    Clin Biochem; 2013 Oct 01; 46(15):1389-93. PubMed ID: 23726814
    [Abstract] [Full Text] [Related]

  • 35. Donor-specific anti-HLA antibodies with antibody-mediated rejection and long-term outcomes following heart transplantation.
    Clerkin KJ, Farr MA, Restaino SW, Zorn E, Latif F, Vasilescu ER, Marboe CC, Colombo PC, Mancini DM.
    J Heart Lung Transplant; 2017 May 01; 36(5):540-545. PubMed ID: 27916323
    [Abstract] [Full Text] [Related]

  • 36. Higher risk of kidney graft failure in the presence of anti-angiotensin II type-1 receptor antibodies.
    Taniguchi M, Rebellato LM, Cai J, Hopfield J, Briley KP, Haisch CE, Catrou PG, Bolin P, Parker K, Kendrick WT, Kendrick SA, Harland RC, Terasaki PI.
    Am J Transplant; 2013 Oct 01; 13(10):2577-89. PubMed ID: 23941128
    [Abstract] [Full Text] [Related]

  • 37. Clinical relevance of pretransplant donor-specific HLA antibodies detected by single-antigen flow-beads.
    Amico P, Hönger G, Mayr M, Steiger J, Hopfer H, Schaub S.
    Transplantation; 2009 Jun 15; 87(11):1681-8. PubMed ID: 19502960
    [Abstract] [Full Text] [Related]

  • 38. The Role of Donor-Specific Antibodies in Intestinal Transplantation: Experience at the University of California Los Angeles and Literature Review.
    Cheng EY, Kaneku H, Farmer DG.
    Clin Transpl; 2014 Jun 15; ():153-9. PubMed ID: 26281140
    [Abstract] [Full Text] [Related]

  • 39. Donor-specific HLA Antibodies Are Associated With Late Allograft Dysfunction After Pediatric Liver Transplantation.
    Wozniak LJ, Hickey MJ, Venick RS, Vargas JH, Farmer DG, Busuttil RW, McDiarmid SV, Reed EF.
    Transplantation; 2015 Jul 15; 99(7):1416-22. PubMed ID: 26038872
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 30.